Mineralocorticoid Receptor Antagonists and Cardiovascular Health with Kidney Failure

Clin J Am Soc Nephrol. 2021 Jun;16(6):843-845. doi: 10.2215/CJN.04460421.

Authors

Qandeel H Soomro¹, David M Charytan

Affiliation

¹ Nephrology Division, Department of Medicine, New York University Langone Medical Center, New York, New York.

No abstract available

Keywords: cardiovascular disease; heart failure; hemodialysis; kidney failure; mineralocorticoid receptor antagonists.

Publication types

Editorial
Comment

MeSH terms

Glomerular Filtration Rate
Humans
Mineralocorticoid Receptor Antagonists* / adverse effects
Renal Insufficiency*
Stroke Volume

Substances

Mineralocorticoid Receptor Antagonists

Associated data

ClinicalTrials.gov/NCT03020303